Skip to contentZ
Zivo Bioscience, Inc.
Z
ZIVOZivo Bioscience, Inc. Q3 2015 · 10-Q
Revenue$0.00$0.00— vs Q3 2014 Net Income-$1.47M-$1.47MN/M vs Q3 2014 EPS Diluted-$0.01-$0.01N/M vs Q3 2014 Operating Income-$788,305N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Zivo Bioscience, Inc. · CIK 1101026 · Engraved from SEC EDGAR
derived
ended Sep 30, 2015 · filed Nov 13, 2015 · 44 d after period end